benzamil has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, H; Hansen, PBL; Jacobsen, IA; Jensen, BL; Jürgensen, JF; Oxlund, CS; Peluso, AA; Staehr, M; Svenningsen, P; Vanhoutte, PM; Ydegaard, R | 1 |
1 trial(s) available for benzamil and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The acute blood pressure-lowering effect of amiloride is independent of endothelial ENaC and eNOS in humans and mice.
Topics: Acid Sensing Ion Channel Blockers; Amiloride; Animals; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Endothelial Cells; Epithelial Sodium Channels; Gene Expression Regulation; Humans; Hypertension; Mice; Mice, Knockout; Nitric Oxide Synthase Type III | 2019 |